Christopher A. Simon's most recent trade in Haemonetics Corp. was a trade of 66,666 Common Stock done . Disclosure was reported to the exchange on May 30, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Haemonetics Corp. | Christopher A. Simon | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2025 | 66,666 | 401,778 (0%) | 0% | 0 | Common Stock | |
| Haemonetics Corp. | Christopher A. Simon | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.38 per share. | 30 May 2025 | 26,234 | 375,544 (0%) | 0% | 69.4 | 1,820,115 | Common Stock |
| Sotera Health Co | Christopher A. Simon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 19,132 | 19,132 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") | |
| Haemonetics Corp. | Christopher A. Simon | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2025 | 46,342 | 46,342 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Haemonetics Corp. | Christopher A. Simon | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2025 | 21,405 | 335,112 (0%) | 0% | - | Common Stock | |
| Haemonetics Corp. | Christopher A. Simon | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.31 per share. | 15 May 2025 | 7,089 | 313,707 (0%) | 0% | 70.3 | 498,428 | Common Stock |
| Haemonetics Corp. | Christopher A. Simon | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.38 per share. | 15 May 2025 | 2,391 | 320,796 (0%) | 0% | 69.4 | 165,888 | Common Stock |
| Haemonetics Corp. | Christopher A. Simon | Director, President & CEO | Other type of transaction at price $ 75.56 per share. | 29 Aug 2024 | 39,704 | 322,838 (0%) | 0% | 75.6 | 3,000,034 | Common Stock |
| Haemonetics Corp. | Christopher A. Simon | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 41.64 per share. | 06 Jun 2024 | 104,516 | 433,877 (0%) | 0% | 41.6 | 4,352,046 | Common Stock |
| Haemonetics Corp. | Christopher A. Simon | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2024 | 104,516 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Haemonetics Corp. | Christopher A. Simon | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.38 per share. | 06 Jun 2024 | 71,335 | 362,542 (0%) | 0% | 87.4 | 6,233,252 | Common Stock |
| Haemonetics Corp. | Christopher A. Simon | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2024 | 106,062 | 371,097 (0%) | 0% | 0 | Common Stock | |
| Haemonetics Corp. | Christopher A. Simon | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 95.73 per share. | 28 May 2024 | 41,736 | 329,361 (0%) | 0% | 95.7 | 3,995,387 | Common Stock |
| Haemonetics Corp. | Christopher A. Simon | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2024 | 32,140 | 32,140 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Haemonetics Corp. | Christopher A. Simon | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2024 | 14,624 | 265,035 (0%) | 0% | - | Common Stock | |
| Haemonetics Corp. | Christopher A. Simon | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 95.73 per share. | 17 May 2024 | 4,037 | 250,411 (0%) | 0% | 95.7 | 386,462 | Common Stock |
| Haemonetics Corp. | Christopher A. Simon | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 94.80 per share. | 15 May 2024 | 1,907 | 254,448 (0%) | 0% | 94.8 | 180,784 | Common Stock |
| Haemonetics Corp. | Christopher A. Simon | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 96.49 per share. | 15 May 2024 | 1,480 | 256,355 (0%) | 0% | 96.5 | 142,805 | Common Stock |
| Haemonetics Corp. | Christopher A. Simon | Director, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 11 Mar 2024 | 38,900 | 257,546 (0%) | 0% | 0 | Common Stock | |
| Haemonetics Corp. | Christopher A. Simon | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jun 2023 | 196,746 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Haemonetics Corp. | Christopher A. Simon | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 28.62 per share. | 29 Jun 2023 | 196,746 | 414,113 (0%) | 0% | 28.6 | 5,629,887 | Common Stock |
| Haemonetics Corp. | Christopher A. Simon | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.84 per share. | 29 Jun 2023 | 117,667 | 296,446 (0%) | 0% | 84.8 | 9,982,868 | Common Stock |
| Haemonetics Corp. | Christopher A. Simon | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.34 per share. | 18 May 2023 | 3,839 | 217,367 (0%) | 0% | 83.3 | 319,942 | Common Stock |
| Haemonetics Corp. | Christopher A. Simon | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 41,177 | 41,177 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Haemonetics Corp. | Christopher A. Simon | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 18,225 | 222,792 (0%) | 0% | - | Common Stock | |
| Haemonetics Corp. | Christopher A. Simon | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 89.21 per share. | 15 May 2023 | 1,586 | 221,206 (0%) | 0% | 89.2 | 141,487 | Common Stock |
| Haemonetics Corp. | Christopher A. Simon | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.16 per share. | 12 May 2023 | 854 | 204,567 (0%) | 0% | 88.2 | 75,289 | Common Stock |
| Haemonetics Corp. | Christopher A. Simon | Director, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 11 Nov 2022 | 8,600 | 205,124 (0%) | 0% | 0 | Common Stock | |
| Haemonetics Corp. | Christopher A. Simon | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 62.60 per share. | 13 Jun 2022 | 1,148 | 213,724 (0%) | 0% | 62.6 | 71,865 | Common Stock |
| Haemonetics Corp. | Christopher A. Simon | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 59.10 per share. | 19 May 2022 | 2,496 | 214,872 (0%) | 0% | 59.1 | 147,514 | Common Stock |
| Haemonetics Corp. | Christopher A. Simon | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2022 | 60,891 | 60,891 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Haemonetics Corp. | Christopher A. Simon | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2022 | 26,041 | 217,368 (0%) | 0% | - | Common Stock | |
| Haemonetics Corp. | Christopher A. Simon | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 56.10 per share. | 16 May 2022 | 832 | 191,327 (0%) | 0% | 56.1 | 46,675 | Common Stock |
| Haemonetics Corp. | Christopher A. Simon | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 59.87 per share. | 14 Jun 2021 | 1,200 | 191,806 (0%) | 0% | 59.9 | 71,844 | Common Stock |
| Haemonetics Corp. | Christopher A. Simon | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 55.09 per share. | 07 Jun 2021 | 2,715 | 193,006 (0%) | 0% | 55.1 | 149,569 | Common Stock |
| Haemonetics Corp. | Christopher A. Simon | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 71,733 | 71,733 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Haemonetics Corp. | Christopher A. Simon | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 26,515 | 196,745 (0%) | 0% | - | Common Stock | |
| Haemonetics Corp. | Christopher A. Simon | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 55.19 per share. | 18 May 2021 | 1,024 | 195,721 (0%) | 0% | 55.2 | 56,515 | Common Stock |
| Haemonetics Corp. | Christopher A. Simon | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 55.97 per share. | 17 May 2021 | 956 | 170,230 (0%) | 0% | 56.0 | 53,507 | Common Stock |
| Haemonetics Corp. | Christopher A. Simon | Director, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Dec 2020 | 194,369 | 170,941 (0%) | 0% | 0 | Common Stock |